Improvement in adenoviral gene transfer efficiency after preincubation at +37°C in vitro and in vivo

Maija Kossila, Suvi Jauhiainen, Mikko O. Laukkanen, Pauliina Lehtolainen, Maiju Jääskeläinen, Päivi Turunen, Sami Loimas, Jarmo Wahlfors, Seppo Ylä-Herttuala

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Adenovirus is a widely used vector in gene transfer experiments because it produces high transduction efficiency in vitro and in vivo by means of the coxsackie-adenovirus receptor (CAR) and major histocompatibility complex (MHC) class 1 α-2 domain. Adenoviral gene transfer efficiency has been reported to correlate with cellular CAR expression. We report here a simple method to increase adenoviral gene transfer efficiency in cells that do not express high levels of CAR: preincubation of adenovirus for 30-40 minutes at +37°C significantly increased the transduction efficiency in vitro in CHO and BALB/3T3 cells, in which CAR is expressed at very low levels. Increased transduction efficiency of preincubated adenovirus was also detected in vivo in rat brain tissue. In addition, we found that adenoviruses were rapidly inactivated in human serum in a complement-independent manner, whereas fetal bovine serum (FBS) had hardly any effects on the viral infectivity. We conclude that preincubation of adenoviral vectors at +37°C may substantially increase gene transfer efficiency in applications in which target cells do not express high levels of CAR.

Original languageEnglish
Pages (from-to)87-93
Number of pages7
JournalMolecular Therapy
Volume5
Issue number1
DOIs
Publication statusPublished - 2002

Fingerprint

Coxsackie and Adenovirus Receptor-Like Membrane Protein
Adenoviridae
Genes
BALB 3T3 Cells
Major Histocompatibility Complex
Serum
In Vitro Techniques
Brain

Keywords

  • Adenovirus
  • Coxsackie adenovirus receptor
  • Gene transfer
  • Serum

ASJC Scopus subject areas

  • Molecular Biology

Cite this

Kossila, M., Jauhiainen, S., Laukkanen, M. O., Lehtolainen, P., Jääskeläinen, M., Turunen, P., ... Ylä-Herttuala, S. (2002). Improvement in adenoviral gene transfer efficiency after preincubation at +37°C in vitro and in vivo. Molecular Therapy, 5(1), 87-93. https://doi.org/10.1006/mthe.2001.0516

Improvement in adenoviral gene transfer efficiency after preincubation at +37°C in vitro and in vivo. / Kossila, Maija; Jauhiainen, Suvi; Laukkanen, Mikko O.; Lehtolainen, Pauliina; Jääskeläinen, Maiju; Turunen, Päivi; Loimas, Sami; Wahlfors, Jarmo; Ylä-Herttuala, Seppo.

In: Molecular Therapy, Vol. 5, No. 1, 2002, p. 87-93.

Research output: Contribution to journalArticle

Kossila, M, Jauhiainen, S, Laukkanen, MO, Lehtolainen, P, Jääskeläinen, M, Turunen, P, Loimas, S, Wahlfors, J & Ylä-Herttuala, S 2002, 'Improvement in adenoviral gene transfer efficiency after preincubation at +37°C in vitro and in vivo', Molecular Therapy, vol. 5, no. 1, pp. 87-93. https://doi.org/10.1006/mthe.2001.0516
Kossila, Maija ; Jauhiainen, Suvi ; Laukkanen, Mikko O. ; Lehtolainen, Pauliina ; Jääskeläinen, Maiju ; Turunen, Päivi ; Loimas, Sami ; Wahlfors, Jarmo ; Ylä-Herttuala, Seppo. / Improvement in adenoviral gene transfer efficiency after preincubation at +37°C in vitro and in vivo. In: Molecular Therapy. 2002 ; Vol. 5, No. 1. pp. 87-93.
@article{6f64737c8830423487e15c2c3f78b6da,
title = "Improvement in adenoviral gene transfer efficiency after preincubation at +37°C in vitro and in vivo",
abstract = "Adenovirus is a widely used vector in gene transfer experiments because it produces high transduction efficiency in vitro and in vivo by means of the coxsackie-adenovirus receptor (CAR) and major histocompatibility complex (MHC) class 1 α-2 domain. Adenoviral gene transfer efficiency has been reported to correlate with cellular CAR expression. We report here a simple method to increase adenoviral gene transfer efficiency in cells that do not express high levels of CAR: preincubation of adenovirus for 30-40 minutes at +37°C significantly increased the transduction efficiency in vitro in CHO and BALB/3T3 cells, in which CAR is expressed at very low levels. Increased transduction efficiency of preincubated adenovirus was also detected in vivo in rat brain tissue. In addition, we found that adenoviruses were rapidly inactivated in human serum in a complement-independent manner, whereas fetal bovine serum (FBS) had hardly any effects on the viral infectivity. We conclude that preincubation of adenoviral vectors at +37°C may substantially increase gene transfer efficiency in applications in which target cells do not express high levels of CAR.",
keywords = "Adenovirus, Coxsackie adenovirus receptor, Gene transfer, Serum",
author = "Maija Kossila and Suvi Jauhiainen and Laukkanen, {Mikko O.} and Pauliina Lehtolainen and Maiju J{\"a}{\"a}skel{\"a}inen and P{\"a}ivi Turunen and Sami Loimas and Jarmo Wahlfors and Seppo Yl{\"a}-Herttuala",
year = "2002",
doi = "10.1006/mthe.2001.0516",
language = "English",
volume = "5",
pages = "87--93",
journal = "Molecular Therapy",
issn = "1525-0016",
publisher = "Nature Publishing Group",
number = "1",

}

TY - JOUR

T1 - Improvement in adenoviral gene transfer efficiency after preincubation at +37°C in vitro and in vivo

AU - Kossila, Maija

AU - Jauhiainen, Suvi

AU - Laukkanen, Mikko O.

AU - Lehtolainen, Pauliina

AU - Jääskeläinen, Maiju

AU - Turunen, Päivi

AU - Loimas, Sami

AU - Wahlfors, Jarmo

AU - Ylä-Herttuala, Seppo

PY - 2002

Y1 - 2002

N2 - Adenovirus is a widely used vector in gene transfer experiments because it produces high transduction efficiency in vitro and in vivo by means of the coxsackie-adenovirus receptor (CAR) and major histocompatibility complex (MHC) class 1 α-2 domain. Adenoviral gene transfer efficiency has been reported to correlate with cellular CAR expression. We report here a simple method to increase adenoviral gene transfer efficiency in cells that do not express high levels of CAR: preincubation of adenovirus for 30-40 minutes at +37°C significantly increased the transduction efficiency in vitro in CHO and BALB/3T3 cells, in which CAR is expressed at very low levels. Increased transduction efficiency of preincubated adenovirus was also detected in vivo in rat brain tissue. In addition, we found that adenoviruses were rapidly inactivated in human serum in a complement-independent manner, whereas fetal bovine serum (FBS) had hardly any effects on the viral infectivity. We conclude that preincubation of adenoviral vectors at +37°C may substantially increase gene transfer efficiency in applications in which target cells do not express high levels of CAR.

AB - Adenovirus is a widely used vector in gene transfer experiments because it produces high transduction efficiency in vitro and in vivo by means of the coxsackie-adenovirus receptor (CAR) and major histocompatibility complex (MHC) class 1 α-2 domain. Adenoviral gene transfer efficiency has been reported to correlate with cellular CAR expression. We report here a simple method to increase adenoviral gene transfer efficiency in cells that do not express high levels of CAR: preincubation of adenovirus for 30-40 minutes at +37°C significantly increased the transduction efficiency in vitro in CHO and BALB/3T3 cells, in which CAR is expressed at very low levels. Increased transduction efficiency of preincubated adenovirus was also detected in vivo in rat brain tissue. In addition, we found that adenoviruses were rapidly inactivated in human serum in a complement-independent manner, whereas fetal bovine serum (FBS) had hardly any effects on the viral infectivity. We conclude that preincubation of adenoviral vectors at +37°C may substantially increase gene transfer efficiency in applications in which target cells do not express high levels of CAR.

KW - Adenovirus

KW - Coxsackie adenovirus receptor

KW - Gene transfer

KW - Serum

UR - http://www.scopus.com/inward/record.url?scp=0036154969&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036154969&partnerID=8YFLogxK

U2 - 10.1006/mthe.2001.0516

DO - 10.1006/mthe.2001.0516

M3 - Article

C2 - 11786050

AN - SCOPUS:0036154969

VL - 5

SP - 87

EP - 93

JO - Molecular Therapy

JF - Molecular Therapy

SN - 1525-0016

IS - 1

ER -